Delivery Order HHSD200201253663I-75D30120F00017
Award Date 10/1/20
Potential Completion Date 11/14/22
Potential Value $500K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Duke University's Office of Research Administration Division. The $263,144.00 award is a delivery order under the CDC's Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract, which has a potential value of $86 million through September 2028. Under this contract, Duke University provides clinical research...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Duke University for the Clinical Immunization Safety Assessment (CISA) program. The $1,044,484 delivery order contract has an ultimate completion date of September 28, 2019 and was not set aside for any socioeconomic designation. As a prime contractor for this CISA IDIQ contract, Duke University will provide clinical research and immunization safety assessment services to the CDC. The CISA program...
- Duke University's Office of Research Administration was awarded a delivery order contract by the CDC Office of Acquisition Services (through its parent Clinical Immunization Safety Assessment (CISA) vehicle) valued at $20,767 on September 29, 2014, with completion targeted for September 28, 2015. The contract was awarded on a cost, no-fee basis without set-aside designation, reflecting a competitive selection based on Duke's technical qualifications. Work was performed at Duke's Durham, North...
- This federal contract was awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Duke University to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a Delivery Order under the CISA master IDIQ contract, which has a potential value of $86 million through September 2028. Two task orders have been awarded to date - one valued at $875,045 for CISA services in Durham, NC from September 2023 to...
- This is a delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Duke University Office Of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The order, valued at $243,907.39, is under a larger CISA IDIQ contract that has a potential value of $86 million through September 2028. As the prime contractor, Duke University will perform the work in Durham, North Carolina. No set-aside...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...
- Duke University Office of Research Administration Division was awarded a cost-no-fee delivery order against a Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC). The $8.3 million delivery order is to support pediatric trials conducted by the National Institutes of Health's National Institute of Child Health and Human Development. As the prime contractor, Duke University will provide...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a private university and non-profit organization, to provide clinical research and immunization safety assessment services. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $465,451.00 and was awarded on September 29, 2015, with a completion date...
- <p>CDC Pittsburgh issued a delivery order to Duke University on September 27, 2012, under the Clinical Immunization Safety Assessment (CISA) parent IDIQ for clinical vaccine safety evaluation contributing contractor functions. The order carried a ceiling value of $235,853.87 under cost-no-fee pricing with an ultimate completion date of September 26, 2017.</p> <p>Place of performance is Durham, NC 27705. Duke University's Office of Research Administration Division executed the work.</p>
- HHSD200201253663IIndefinite Delivery Contract
- HHSD200201253663I-75D30120F00017Delivery Order
Duke University Office of Research Administration Division was awarded a $499,784 firm fixed price delivery order against its Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC). The delivery order is for a CISA SHINGRIX lead study to be performed in Durham, North Carolina by November 2022. Duke University holds the CISA IDIQ contract with CDC, valued at up to $86 million through September 2028, to provide clinical research and immunization safety assessment services in support of CDC programs. No set-aside designation was specified for this delivery order award.
Generated 3/1/24, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | ($40k) | 2/29/24 | |
| P00002 | Additional Work (new agreement, FAR part 6 applies) | $0 | 7/13/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 1/6/22 | |
| Not listed | Not listed | $496.8k | 9/3/20 |